GlassScriptPhysician profile
Meredith L Lightfoot
NPI 1083661052
$9,097.44
in general payments reported to CMS, 2019-2025
52 companies · $2,530 in 2025
The $2,530 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $348 · 2021: $816 · 2022: $1,226 · 2023: $1,405 · 2024: $1,936 · 2025: $2,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,804 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,803.54 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,258.94 | 2019-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $1,222.36 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $890.74 | 2019-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $824.95 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $620.11 | 2019-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $401.11 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $393.93 | 2019-2025 | |
| Urovant Sciences INC | $334.73 | 2021-2022 | |
| Pfizer INC. | $323.45 | 2019-2025 | |
| Axonics, INC. | $233.47 | 2022-2024 | Bulkamid, Axonics |
| Tempus Ai, INC | $194.51 | 2024 | |
| Merck Sharp & Dohme LLC | $194.41 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Myovant Sciences INC. | $184.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $183.92 | 2023-2025 | |
| Boston Scientific Corporation | $178.68 | 2019-2025 | Lithovue, Rezum Generator |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Lightfoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.